Pharmacokinetics and Pharmacodynamics of Oxycodone When Given Intravenously and Rectally to Adult Patients with Cancer Pain
Authors:
- Tess CramondTCTess Cramond
- Maree T. SmithMaree T. Smith
- 1 February 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 80 (2) , 296-302
Abstract
The single-dose pharmacokinetics and pharmacodynamics of oxycodone administered by the intravenous and rectal routes were determined in 12 adult cancer patients with moderate to severe cancer pain (visual analog scale [VAS] score, approximately 5). Oxycodone was administered by the intravenous and rectal routes with open drug administration and a cross-over design. After single-dose intravenous administration (7.9 +/- 1.5 mg, mean +/- SD), the mean (+/- SD) terminal half-life was 3.4 h (+/- 1.1), the mean (+/- SD) plasma clearance was 45.4 L/h (+/- 10.1), and the mean (+/- SD) volume of distribution in the terminal phase was 3.0 L/kg (+/- 1.1). After rectal oxycodone (30 mg), the mean (+/- SD) absorption lag time was 0.52 h (+/- 0.29) and the mean (+/- SD) absolute bioavailability was 61.6% (+/- 30.2%). Intravenous oxycodone was associated with a rapid onset of pain relief (5-8 min) in contrast to the 0.5- to 1.0-h delay observed after rectal administration. However, rectal oxycodone provided analgesia of much longer duration (approximately 8-12 h) than did intravenous oxycodone (approximately 4 h). There were no significant differences (P > 0.05) in the incidence and severity of side effects between intravenous and rectal oxycodone. The marked interindividual variation observed in the pharmacokinetics and pharmacodynamics of oxycodone in this study emphasizes the need for individualized dosing regimens.Keywords
This publication has 22 references indexed in Scilit:
- Comparative Oxycodone Pharmacokinetics in Humans After Intravenous, Oral, and Rectal AdministrationTherapeutic Drug Monitoring, 1992
- Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancerClinical Pharmacology & Therapeutics, 1992
- The pharmacokinetics of oxycodone after intravenous injection in adults.British Journal of Clinical Pharmacology, 1991
- Intravenous morphine and oxycodone for pain after abdominal surgeryActa Anaesthesiologica Scandinavica, 1991
- Quantitation of Oxycodone in Human Plasma Using High-Performance Liquid Chromatography with Electrochemical DetectionTherapeutic Drug Monitoring, 1991
- Morphine and Oxycodone in the Management of Cancer Pain: Plasma Levels Determined by Chemical and Radioreceptor AssaysBasic & Clinical Pharmacology & Toxicology, 1990
- Morphine and oxycodone hydrochloride in the management of cancer painClinical Pharmacology & Therapeutics, 1990
- Diclofenac and oxycodone in treatment of postoperative pain: a double‐blind trialActa Anaesthesiologica Scandinavica, 1986
- COMPARISON OF I.M. LYSINE ACETYLSALICYLATE AND OXYCODONE IN THE TREATMENT OF PAIN AFTER OPERATIONBritish Journal of Anaesthesia, 1980
- Controlled Comparison of the Efficacy of Fourteen Preparations in the Relief of Postoperative PainBMJ, 1971